CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 61 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,328,834 | -45.0% | 7,786,139 | -3.6% | 0.00% | – |
| Q2 2023 | $9,695,057 | +254.2% | 8,079,215 | +245.3% | 0.00% | – |
| Q1 2023 | $2,737,224 | +48.4% | 2,339,507 | +0.2% | 0.00% | – |
| Q4 2022 | $1,844,365 | -34.6% | 2,334,639 | +0.1% | 0.00% | – |
| Q3 2022 | $2,822,000 | +30.6% | 2,332,099 | -0.6% | 0.00% | – |
| Q2 2022 | $2,160,000 | -85.1% | 2,347,292 | -71.0% | 0.00% | – |
| Q1 2022 | $14,468,000 | +15.6% | 8,082,179 | -0.6% | 0.00% | – |
| Q4 2021 | $12,518,000 | -24.4% | 8,128,256 | -0.4% | 0.00% | – |
| Q3 2021 | $16,561,000 | -41.4% | 8,158,054 | +0.4% | 0.00% | -100.0% |
| Q2 2021 | $28,272,000 | +723.5% | 8,124,526 | +321.3% | 0.00% | – |
| Q1 2021 | $3,433,000 | – | 1,928,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |